Related Experiment Video
Updated: Mar 23, 2026

08:27
Large-Scale Multi-Omics Genome-Wide Association Studies Mo-GWAS: Guidelines for Sample Preparation and Normalization
Published on: July 27, 2021
5.0K
[Genome-wide association study for rheumatoid arthritis]
1Laboratory for Autoimmune Diseases, Center for Integrative Medical Sciences, RIKEN, Japan.
Summary
Rheumatoid arthritis (RA) is a complex disease influenced by genes and environment. This review covers key RA-associated genes, including HLA-DRB1, PADI4, and CCR6, identified through genetic studies.
Area of Science:
- Genetics and Immunology
- Molecular Biology
Context:
- Rheumatoid arthritis (RA) is a multifactorial autoimmune disease.
- Genetic and environmental factors contribute to RA pathogenesis.
- Genome-wide association studies (GWAS) have identified over 100 RA-associated genetic loci.
Purpose:
- To review the genetic underpinnings of rheumatoid arthritis.
- To highlight the role of genetic variants in regulating gene expression in RA.
- To discuss specific RA-associated genes and their significance.
Summary:
- The majority of RA-associated loci identified by GWAS are expression quantitative trait loci (eQTLs).
- These eQTLs demonstrate how genetic variants influence transcription levels, impacting disease development.
- Key RA-associated genes discussed include HLA-DRB1, PADI4, and CCR6, which play crucial roles in immune function and inflammation.
Impact:
- Provides a comprehensive overview of the genetic architecture of RA.
- Enhances understanding of how genetic variations contribute to RA susceptibility and progression.
- Informs future research directions for targeted therapies and genetic risk prediction in rheumatoid arthritis.
Related Concept Videos
Genome-wide Association Studies-GWAS
16.6K
Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
GWAS does not require the identification of the target gene involved in...
16.6K
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies
970
The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
970
The JAK-STAT Signaling Pathway
13.8K
Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as SH2...
13.8K
Rheumatic Heart Disease I: Introduction
821
Rheumatic heart disease or RHD is a chronic condition that results from rheumatic fever, causing permanent damage to the heart valves.Etiology and Risk FactorsIt primarily arises from rheumatic fever, an inflammatory disease that can develop after untreated or inadequately treated group A streptococcal (GAS) pharyngitis. Streptococcus spreads through direct contact with oral or respiratory secretions. While the bacteria are the causative agents, factors like malnutrition, overcrowding, poor...
821

